Incyte Corp. ’s (INCY) share price has entered into oversold territory with a stochastic value of 3.9747. The Zacks Consensus Estimate on the company’s loss for year ending December 2012 decreased by 4 cents over the past week to a loss of 61 cents per share. Incyte Corp. is a Zacks #2 Rank (“Buy”) company.
INCYTE GENOMICS INC (INCY): Free Stock Analysis Report
More From Zacks.com
